This section is not available in the published analysis.
TrueBinding Inc.: Audience
TrueBinding Inc. is a clinical stage biotherapeutic company focused on developing novel monoclonal antibody therapeutics for neurodegenerative and metabolic diseases, stroke, and oncology. The company aims to address significant unmet medical needs through innovative treatments.